PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs BSX |
|---|---|---|---|---|---|
| ZBH | Zimmer Biomet Holdings, Inc. | 0.65 | 23.9 | 36.8% | +97% |
| SYK | Stryker Corporation | 2.32 | 34.4 | 14.8% | +604% |
| BDX | Becton, Dickinson and Company | 3.37 | 54.8 | 16.3% | +922% |
| ABT | Abbott Laboratories | 4.32 | 35.5 | 8.2% | +1208% |
| EW | Edwards Lifesciences Corporation | 7.60 | 52.2 | 6.9% | +2201% |